At the same time, in the control H522(Kat+), PC-3M(Kat+), A431(Kat+), and MDA-MB-231(Kat+CD19+) cells the addition of CAR-T cells did not result in a consistent reduction in the tumor cells’ confluence throughout the entire period of cultivation (7 days). This evidence concerns the gene CD19 and neoplasm.